CURIS INC
Biological Products, (No Diagnostic Substances) · LEXINGTON · MA
Moderate confidence (50%)
Updated Oct 11, 2026, 12:05 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: CURIS INC received a delisting notice from its exchange (Jul 24, 2026)
Timeline
Every material event, newest first. History is never overwritten.
CURIS INC received a delisting notice from its exchange
Jul 24, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 24, 2026, Curis, Inc. (the Company ) received written notice from the Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ) and is in full compliance with the terms set forth by the Nasdaq Hearings Panel (the Panel ). Pursuant to Listing Rule 5815(d)(4)(A), the Company will be subject to a Discretionary Panel Monitor for a one-year period from July 24, 2026. If the Company fails to main…”
CURIS INC received a delisting notice from its exchange
Apr 27, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on February 3, 2026, Curis, Inc. (the Company ) became subject to a Discretionary Panel Monitor for a period of one-year pursuant to Listing Rule 5815(d)(4)(A). If, within the one-year monitoring period, the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) finds the Company again out of compliance with any of Nasdaq s Listing Rules, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide the Staff with…”
CURIS INC received a delisting notice from its exchange
Feb 3, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 3, 2026, Curis, Inc. (the Company ) received written notice from the Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(2) ( MVLS Rule ) and is in full compliance with the terms set forth by the Nasdaq Hearings Panel (the Panel ). Pursuant to Listing Rule 5815(d)(4)(A), the Company will be subject to a Discretionary Panel Monitor for a period of one-year. If, within the one-year monitoring period, the Li…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Biological Products, (No Diagnostic Substances)
- Subindustry
- —
- Listing
- SEC lists the ticker CRIS on Nasdaq.
- SEC CIK
- 0001108205
- Website
- —
- —
- Headquarters
- LEXINGTON, MA
- Also known as
- —
- Legal entities
- CURIS INC
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
CURIS INC — Biological Products, (No Diagnostic Substances) (SIC 2836) — LEXINGTON, MA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. As previously disclosed, on February 3, 2026, Curis, Inc. (the Company ) became subject to a Discretionary Panel Monitor for a period of one-year pursuant to Listing Rule 5815(d)(4)(A). If, within the one-year monitoring period, the Listing Qualifications Department (the Staff ) of the Nasdaq Stock Market ( Nasdaq ) finds the Company again out of compliance with any of Nasdaq s Listing Rules, notwithstanding Rule 5810(c)(2), the Company will not be permitted to provide the Staff with…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On February 3, 2026, Curis, Inc. (the Company ) received written notice from the Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company has regained compliance with Nasdaq Listing Rule 5550(b)(2) ( MVLS Rule ) and is in full compliance with the terms set forth by the Nasdaq Hearings Panel (the Panel ). Pursuant to Listing Rule 5815(d)(4)(A), the Company will be subject to a Discretionary Panel Monitor for a period of one-year. If, within the one-year monitoring period, the Li…
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On July 24, 2026, Curis, Inc. (the Company ) received written notice from the Nasdaq Stock Market LLC ( Nasdaq ) indicating that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) (the Bid Price Rule ) and is in full compliance with the terms set forth by the Nasdaq Hearings Panel (the Panel ). Pursuant to Listing Rule 5815(d)(4)(A), the Company will be subject to a Discretionary Panel Monitor for a one-year period from July 24, 2026. If the Company fails to main…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 12, 2026, 12:15 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 03:27 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.